Trials for anti-coronavirus drug dexamethasone begin in UK
This is the first human trial of the new vaccine developed by Imperial College London. This development and trial is independent of the vaccine project at Oxford.
Following on from the discovery that the simple drug dexamethasone can bring new hope for thousands suffering severely from the novel coronavirus, a major new trial of a vaccine has begun on Wednesday in the United Kingdom. This is the first human trial of the new vaccine developed by Imperial College London. This development and trial is independent of the vaccine project at Oxford.
The trials will “test whether it is well-tolerated and produces an effective immune response against Covid-19”, according to Imperial College.The UK government has given 41 million pounds for funding development of this vaccine. An additional five million pounds have come by way of individual and institutional gifts.
“The trials will be the first test of a new self-amplifying RNA (genetic code) technology, which has the potential to revolutionise vaccine development and enable scientists to respond more quickly to emerging diseases,” Imperial said in its statement.